Financial Ratios ORIX Corporation

Equities

8591

JP3200450009

Consumer Lending

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-04-14 am EDT			5-day change	1st Jan Change
4,982.00 ^JPY	+3.04%		+6.43%	+9.40%

02:54am	Japan Stocks Rise as Wall Street Gains Lift Sentiment Amid Iran Talks Hopes	MT
09:52pm	Orix To Exit IX NTI Holdings in Sale to Olympus Partners Unit	MT

d84845a24b7855.rUKEEsrhMzR0pusNs1B_CxuVlOhPGXgO7g7LdTE9QxM._XDsYvy2WXIC0axV0GIWcyP-07woSiFttG-CNF4OBX7JCuVAnKlHBUHorg

Published financial data: ORIX CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	1,975B	2,184B	2,316B	2,433B	2,532B
Gain (Loss) on Sale of Investment, Total (Rev)	44.63B	56.6B	32.94B	33.78B	16.06B
Interest And Invest. Income (Rev)	251B	261B	101B	114B	121B
Other Revenues, Total	21.67B	18.9B	216B	234B	205B
Total Revenues	2,293B	2,520B	2,666B	2,814B	2,875B
Cost of Goods Sold, Total	1,456B	1,575B	1,652B	1,640B	1,674B
Gross Profit	837B	946B	1,014B	1,174B	1,201B
Selling General & Admin Expenses, Total	474B	523B	559B	628B	646B
Other Operating Expenses	16.26B	-5.44B	11.75B	-5.7B	9.35B
Other Operating Expenses, Total	490B	517B	571B	622B	655B
Operating Income	347B	428B	443B	552B	545B
Interest Expense, Total	-78.08B	-68.25B	-128B	-188B	-169B
Net Interest Expenses	-78.08B	-68.25B	-128B	-188B	-169B
Income (Loss) On Equity Invest.	481M	15.01B	25.09B	36.77B	57.18B
Currency Exchange Gains (Loss)	1.8B	-3.35B	-1.96B	-1.13B	-3.52B
Other Non Operating Income (Expenses)	-	4.45B	4.54B	-	-
EBT, Excl. Unusual Items	271B	376B	343B	400B	430B
Impairment of Goodwill	-1.51B	-562M	-	-	-
Gain (Loss) On Sale Of Investments	-5.94B	-751M	-803M	-315M	-554M
Gain (Loss) On Sale Of Assets	23.3B	188B	26.92B	72.49B	87.7B
Asset Writedown	-4.17B	-57.66B	-2.81B	-1.72B	-40.23B
Other Unusual Items	4.97B	-	1.17B	-	3.75B
EBT, Incl. Unusual Items	288B	505B	367B	470B	480B
Income Tax Expense	90.75B	187B	87.5B	131B	129B
Earnings From Continuing Operations	197B	318B	280B	339B	352B
Net Income to Company	197B	318B	280B	339B	352B
Minority Interest	-4.43B	-5.48B	-6.59B	7.54B	-5M
Net Income - (IS)	192B	312B	273B	346B	352B
Preferred Dividend and Other Adjustments	-	-	-	7M	35M
Net Income to Common Incl Extra Items	192B	312B	273B	346B	352B
Net Income to Common Excl. Extra Items	192B	312B	273B	346B	352B
Per Share Items
Net EPS - Basic	155.54	259.37	231.35	298.55	307.74
Basic EPS - Continuing Operations	155.54	259.37	231.35	298.55	307.74
Basic Weighted Average Shares Outstanding	1.24B	1.2B	1.18B	1.16B	1.14B
Net EPS - Diluted	155.39	259.07	231.04	298.05	307.16
Diluted EPS - Continuing Operations	155.39	259.07	231.04	298.05	307.16
Diluted Weighted Average Shares Outstanding	1.24B	1.2B	1.18B	1.16B	1.14B
Normalized Basic EPS	133.3	190.76	175.87	221.89	235.11
Normalized Diluted EPS	133.18	190.53	175.63	221.52	234.64
Dividend Per Share	78	85.6	85.6	98.6	120.01
Payout Ratio	49.47	31.84	38.92	28.86	38.56
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	663B	759B	796B	916B	945B
EBITA	375B	460B	443B	591B	587B
EBIT	347B	428B	443B	552B	545B
EBITDAR	705B	808B	844B	966B	995B
Total Revenues (As Reported)	2,293B	2,520B	2,666B	2,814B	2,875B
Effective Tax Rate - (Ratio)	31.56	37.09	23.83	27.96	26.81
Current Domestic Taxes	45.26B	137B	30.81B	80.27B	72.23B
Current Foreign Taxes	19.97B	38.43B	27.49B	31.11B	33.25B
Total Current Taxes	65.23B	175B	58.3B	111B	105B
Deferred Domestic Taxes	10.64B	-631M	14.3B	9.05B	26.8B
Deferred Foreign Taxes	14.88B	12.84B	14.9B	10.95B	-3.46B
Total Deferred Taxes	25.52B	12.21B	29.2B	20B	23.35B
Normalized Net Income	165B	230B	208B	257B	269B
Interest Capitalized	858M	-	-	-	-
Interest on Long-Term Debt	989M	106M	150M	84M	67M
Non-Cash Pension Expense	-2.45B	-4.21B	-5.01B	-4.82B	-6.07B
Supplemental Operating Expense Items
Advertising Expense	17.31B	-	-	-	-
Selling and Marketing Expenses	17.31B	-	-	-	-
Net Rental Expense, Total	42.4B	49.63B	47.5B	49.66B	50.38B
Imputed Operating Lease Interest Expense	5.37B	5.31B	8.7B	11.99B	10.47B
Imputed Operating Lease Depreciation	37.03B	44.32B	38.8B	37.67B	39.91B
Stock-Based Comp., Other (Total)	885M	1.19B	937M	2.18B	1.78B
Total Stock-Based Compensation	885M	1.19B	937M	2.18B	1.78B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	951B	955B	1,232B	1,033B	1,207B
Short Term Investments	4.15B	4.2B	4.37B	2.03B	1.4B
Trading Asset Securities, Total	4.52B	12.07B	55.41B	19B	17.87B
Total Cash And Short Term Investments	960B	971B	1,292B	1,054B	1,226B
Accounts Receivable, Total	5,010B	5,256B	5,397B	5,525B	5,662B
Other Receivables	6.3B	5.21B	4.68B	2.79B	17.13B
Total Receivables	5,016B	5,261B	5,402B	5,528B	5,679B
Inventory	142B	140B	169B	227B	229B
Restricted Cash	128B	137B	135B	152B	115B
Other Current Assets, Total	20.83B	41.8B	19.16B	53.99B	46.3B
Total Current Assets	6,268B	6,550B	7,017B	7,016B	7,295B
Gross Property Plant And Equipment	1,053B	1,131B	1,228B	1,315B	1,341B
Accumulated Depreciation	-201B	-221B	-255B	-290B	-303B
Net Property Plant And Equipment	853B	910B	973B	1,025B	1,037B
Long-term Investments	3,296B	3,643B	3,788B	4,416B	4,422B
Goodwill	495B	489B	628B	632B	622B
Other Intangibles, Total	489B	474B	590B	613B	602B
Deferred Tax Assets Long-Term	38.95B	46.06B	48.29B	66.52B	63.34B
Other Long-Term Assets, Total	2,124B	2,159B	2,222B	2,554B	2,824B
Total Assets	13,563B	14,271B	15,266B	16,322B	16,866B
Liabilities
Accounts Payable, Total	261B	291B	367B	363B	340B
Short-term Borrowings	14.42B	40.06B	44.52B	134B	88.22B
Current Portion of Long-Term Debt	1,021B	1,161B	1,345B	1,325B	1,332B
Current Portion of Leases	48.8B	48.57B	54B	51.47B	53.12B
Current Income Taxes Payable	22.17B	115B	25.2B	65.53B	53.15B
Other Current Liabilities	1,178B	1,212B	1,279B	1,124B	1,511B
Total Current Liabilities	2,545B	2,868B	3,115B	3,062B	3,377B
Long-Term Debt	3,712B	3,674B	4,332B	4,745B	4,865B
Long-Term Leases	245B	234B	234B	209B	206B
Unearned Revenue Non Current	40.44B	32.98B	34.34B	32.83B	40.44B
Pension & Other Post Retirement Benefits	23.85B	15.46B	16.97B	17.5B	16.94B
Deferred Tax Liability Non Current	341B	346B	360B	505B	526B
Other Non Current Liabilities	3,552B	3,729B	3,746B	3,726B	3,659B
Total Liabilities	10,460B	10,899B	11,838B	12,297B	12,691B
Common Stock, Total	221B	221B	221B	221B	221B
Additional Paid In Capital	259B	260B	233B	233B	234B
Retained Earnings	2,745B	2,909B	3,032B	3,260B	3,355B
Treasury Stock	-112B	-113B	-121B	-130B	-61.73B
Comprehensive Income and Other	-84.65B	-16.04B	-8.38B	357B	341B
Total Common Equity	3,028B	3,261B	3,357B	3,941B	4,090B
Minority Interest	74.69B	110B	71.66B	83.14B	85.43B
Total Equity	3,103B	3,371B	3,428B	4,025B	4,175B
Total Liabilities And Equity	13,563B	14,271B	15,266B	16,322B	16,866B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.22B	1.19B	1.17B	1.15B	1.14B
ECS Total Common Shares Outstanding	1.22B	1.19B	1.17B	1.15B	1.14B
Book Value / Share	2.49K	2.73K	2.87K	3.42K	3.6K
Tangible Book Value	2,044B	2,299B	2,138B	2,697B	2,866B
Tangible Book Value Per Share	1.68K	1.93K	1.83K	2.34K	2.52K
Total Debt	5,041B	5,158B	6,010B	6,464B	6,545B
Net Debt	4,081B	4,187B	4,718B	5,411B	5,319B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-11.12B	-32.41B	-40.83B	-61.86B	-72.98B
Debt Equivalent Oper. Leases	339B	397B	380B	397B	403B
Minority Interest, Total (Incl. Fin. Div)	74.69B	110B	71.66B	83.14B	85.43B
Equity Method Investments, Total	970B	1,069B	1,092B	1,314B	1,320B
Account Code - Inventory Valuation	8	8	8	8	8
Inventories - Work In Process, Total	57.5B	62.41B	74.62B	118B	116B
Inventories - Finished Goods, Total	84.65B	77.15B	94.4B	109B	113B
Full Time Employees	33.15K	32.24K	34.74K	33.81K	33.98K
Accumulated Allowance for Doubtful Accounts (Supple)	79.25B	70.37B	68.31B	61.24B	58.26B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	192B	312B	273B	346B	352B
Depreciation & Amortization - CF	287B	298B	353B	325B	358B
Amortization of Goodwill and Intangible Assets - (CF)	28.75B	32.24B	-	39.21B	41.4B
Depreciation & Amortization, Total	316B	330B	353B	364B	400B
(Gain) Loss From Sale Of Asset	-49.66B	-228B	-83.85B	-126B	-164B
(Gain) Loss on Sale of Investments - (CF)	-9.29B	-21.59B	-7.92B	-3.63B	7.33B
Asset Writedown & Restructuring Costs	3.02B	35.67B	2.3B	1.72B	25.93B
Provision for Credit Losses	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	837M	-13.75B	-24.02B	-36.77B	-57.18B
Provision and Write-off of Bad Debts	16.02B	3.94B	7.76B	20.97B	18.72B
Other Operating Activities, Total	421B	371B	404B	448B	447B
Change in Trading Asset Securities	12.1B	68.42B	31.86B	-8.04B	28.49B
Change In Accounts Receivable	-12.66B	3.56B	12.95B	5.24B	-2.64B
Change In Inventories	-12.06B	-7.05B	-17.53B	-58.13B	-9.84B
Change In Accounts Payable	-1.95B	14.94B	-12.17B	-4.43B	-3.91B
Change In Income Taxes	-11.04B	92.03B	-129B	108B	-9.23B
Change in Other Net Operating Assets	231B	141B	102B	186B	268B
Cash from Operations	1,096B	1,103B	913B	1,243B	1,300B
Capital Expenditure	-754B	-917B	-1,080B	-1,201B	-1,358B
Sale of Property, Plant, and Equipment	139B	147B	233B	263B	374B
Cash Acquisitions	-82.16B	-87.58B	-207B	-42.49B	-89.87B
Divestitures	57.72B	253B	19.99B	140B	111B
Investment in Marketable and Equity Securities, Total	-489B	-206B	-122B	-471B	-168B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-59.37B	-19.94B	51.17B	-73.15B	-204B
Other Investing Activities, Total	-15.77B	22.12B	5.72B	12.54B	24.97B
Cash from Investing	-1,203B	-809B	-1,098B	-1,373B	-1,310B
Short Term Debt Issued, Total	-	96.38B	20.41B	10.75B	-
Long-Term Debt Issued, Total	1,171B	950B	1,826B	1,219B	1,600B
Total Debt Issued	1,171B	1,047B	1,846B	1,230B	1,600B
Short Term Debt Repaid, Total	-42.14B	-	-	-	-98.62B
Long-Term Debt Repaid, Total	-1,031B	-1,168B	-1,159B	-1,178B	-1,368B
Total Debt Repaid	-1,074B	-1,168B	-1,159B	-1,178B	-1,467B
Repurchase of Common Stock	-55.44B	-50B	-52.07B	-50B	-53.52B
Common Dividends Paid	-95.16B	-99.4B	-106B	-99.9B	-136B
Common & Preferred Stock Dividends Paid	-95.16B	-99.4B	-106B	-99.9B	-136B
Other Financing Activities, Total	92.71B	-35.74B	-90.86B	12.61B	206B
Cash from Financing	39.88B	-307B	438B	-85.48B	149B
Foreign Exchange Rate Adjustments	11.98B	24.33B	22.18B	33.28B	-3.14B
Net Change in Cash	-55.71B	12.24B	275B	-182B	137B
Supplemental Items
Cash Interest Paid	80.31B	65.96B	118B	183B	168B
Cash Income Tax Paid (Refund)	76.29B	83.03B	187B	3.51B	113B
Levered Free Cash Flow	986B	656B	492B	305B	569B
Unlevered Free Cash Flow	1,035B	699B	572B	423B	674B
Change In Net Working Capital	-1,255B	-1,017B	-1,021B	-912B	-1,290B
Net Debt Issued / Repaid	97.78B	-121B	688B	51.82B	133B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	1.63	1.92	1.87	2.18	2.05
Return on Total Capital	2.68	3.21	3.08	3.43	3.21
Return On Equity %	6.37	9.81	8.23	8.86	8.58
Return on Common Equity	6.39	9.92	8.25	9.25	8.76
Margin Analysis
Gross Profit Margin %	36.51	37.52	38.03	41.72	41.76
SG&A Margin	20.68	20.74	20.98	22.3	22.47
EBITDA Margin %	28.9	30.1	29.86	32.56	32.86
EBITA Margin %	16.38	18.27	16.61	21.01	20.4
EBIT Margin %	15.12	16.99	16.61	19.62	18.96
Income From Continuing Operations Margin %	8.58	12.6	10.49	12.03	12.23
Net Income Margin %	8.39	12.38	10.24	12.3	12.23
Net Avail. For Common Margin %	8.39	12.38	10.24	12.3	12.23
Normalized Net Income Margin	7.19	9.11	7.79	9.14	9.34
Levered Free Cash Flow Margin	43.01	26.04	18.46	10.83	19.78
Unlevered Free Cash Flow Margin	45.14	27.73	21.46	15.01	23.46
Asset Turnover
Asset Turnover	0.17	0.18	0.18	0.18	0.17
Fixed Assets Turnover	2.63	2.86	2.83	2.82	2.79
Receivables Turnover (Average Receivables)	0.39	0.43	0.43	0.44	0.45
Inventory Turnover (Average Inventory)	10.86	11.18	10.71	8.28	7.33
Short Term Liquidity
Current Ratio	2.46	2.28	2.25	2.29	2.16
Quick Ratio	2.35	2.17	2.15	2.15	2.04
Operating Cash Flow to Current Liabilities	0.43	0.38	0.29	0.41	0.38
Days Sales Outstanding (Average Receivables)	934.64	857.73	839.32	823.44	806.27
Days Outstanding Inventory (Average Inventory)	33.62	32.65	34.08	44.22	49.77
Average Days Payable Outstanding	67.39	64.09	71.43	78.57	76.47
Cash Conversion Cycle (Average Days)	900.88	826.29	801.97	789.09	779.57
Long Term Solvency
Total Debt/Equity	162.46	152.99	175.3	160.62	156.76
Total Debt / Total Capital	61.9	60.47	63.68	61.63	61.05
LT Debt/Equity	127.5	115.93	133.2	123.1	121.47
Long-Term Debt / Total Capital	48.58	45.83	48.38	47.23	47.31
Total Liabilities / Total Assets	77.12	76.38	77.54	75.34	75.25
EBIT / Interest Expense	4.44	6.27	3.46	2.93	3.23
EBITDA / Interest Expense	9.03	11.84	6.6	5.13	5.89
(EBITDA - Capex) / Interest Expense	-0.63	-1.6	-1.85	-1.25	-2.15
Total Debt / EBITDA	7.15	6.38	7.12	6.69	6.58
Net Debt / EBITDA	5.79	5.18	5.59	5.6	5.35
Total Debt / (EBITDA - Capex)	-103.09	-47.28	-25.43	-27.53	-18.05
Net Debt / (EBITDA - Capex)	-83.46	-38.38	-19.97	-23.04	-14.67
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	0.54	9.93	5.79	5.66	2.15
Gross Profit, 1 Yr. Growth %	-4.38	16.39	7.24	12.83	2.26
EBITDA, 1 Yr. Growth %	-3.9	15.75	4.97	13.19	3.09
EBITA, 1 Yr. Growth %	-10.08	25.08	3.42	17.43	-0.81
EBIT, 1 Yr. Growth %	-10.03	26.18	3.42	17.63	-1.26
Earnings From Cont. Operations, 1 Yr. Growth %	-35.83	61.38	-11.95	14.03	3.85
Net Income, 1 Yr. Growth %	-36.44	62.25	-12.51	19.22	1.59
Normalized Net Income, 1 Yr. Growth %	-23.79	39.17	-9.57	17.23	4.42
Diluted EPS Before Extra, 1 Yr. Growth %	-34.48	66.72	-10.82	21.33	3.06
Accounts Receivable, 1 Yr. Growth %	-1.89	4.9	2.69	1.87	2.47
Inventory, 1 Yr. Growth %	12.81	-1.82	21.11	34.52	0.82
Net Property, Plant and Equip., 1 Yr. Growth %	-3.99	6.74	6.93	5.38	1.16
Total Assets, 1 Yr. Growth %	3.79	5.22	6.98	6.75	3.33
Tangible Book Value, 1 Yr. Growth %	-2.09	12.47	-6.97	15.98	6.27
Common Equity, 1 Yr. Growth %	1.16	7.69	2.92	11.23	3.76
Cash From Operations, 1 Yr. Growth %	5.1	0.09	-17.25	36.18	4.57
Capital Expenditures, 1 Yr. Growth %	-24.07	20.59	17.75	11.18	13.06
Levered Free Cash Flow, 1 Yr. Growth %	-198.64	-521.36	-207.51	-139.46	-176.78
Unlevered Free Cash Flow, 1 Yr. Growth %	-210.36	-753.51	-237.79	-160.99	-208.24
Dividend Per Share, 1 Yr. Growth %	2.63	9.74	0	15.19	21.71
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-2.79	5.13	7.84	5.93	3.89
Gross Profit, 2 Yr. CAGR %	-2.3	4.92	11.72	11.71	7.42
EBITDA, 2 Yr. CAGR %	-3.83	4.88	10.23	11	7.79
EBITA, 2 Yr. CAGR %	-8.93	5.01	14.23	13.92	7.56
EBIT, 2 Yr. CAGR %	-9.25	5.42	14.23	14.19	7.38
Earnings From Cont. Operations, 2 Yr. CAGR %	-22.42	1.76	19.2	2.41	8.82
Net Income, 2 Yr. CAGR %	-22.91	1.55	19.14	4.43	10.05
Normalized Net Income, 2 Yr. CAGR %	-14.58	3.01	12.18	5.81	10.1
Diluted EPS Before Extra, 2 Yr. CAGR %	-21.58	4.52	21.94	6.37	11.82
Accounts Receivable, 2 Yr. CAGR %	3.36	1.45	3.79	2.53	2.17
Inventory, 2 Yr. CAGR %	10.85	5.24	9.04	27.64	16.46
Net Property, Plant and Equip., 2 Yr. CAGR %	24.5	1.23	6.84	6.15	3.25
Total Assets, 2 Yr. CAGR %	5.55	4.5	6.09	6.95	5.03
Tangible Book Value, 2 Yr. CAGR %	0.9	4.93	2.29	8.32	11.02
Common Equity, 2 Yr. CAGR %	2.24	4.38	5.28	9.93	7.43
Cash From Operations, 2 Yr. CAGR %	36.54	2.88	-8.99	6.16	19.33
Capital Expenditures, 2 Yr. CAGR %	-15.67	-3.88	19.16	14.42	12.12
Levered Free Cash Flow, 2 Yr. CAGR %	2.77	-18.98	77.78	-19.53	-14.09
Unlevered Free Cash Flow, 2 Yr. CAGR %	8.37	-13.67	131.3	-0.67	-1.19
Dividend Per Share, 2 Yr. CAGR %	1.31	6.13	4.76	7.33	18.41
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-7.13	1.28	5.35	7.07	4.65
Gross Profit, 3 Yr. CAGR %	-1.55	2.54	5.69	13.06	8.47
EBITDA, 3 Yr. CAGR %	-1.59	1.92	4.91	11.82	8.3
EBITA, 3 Yr. CAGR %	-5.59	0.57	1.98	20.33	8.78
EBIT, 3 Yr. CAGR %	-5.84	0.57	4.75	17.61	8.79
Earnings From Cont. Operations, 3 Yr. CAGR %	-15.1	-0.97	-3.03	19.82	2.89
Net Income, 3 Yr. CAGR %	-14.99	-1.21	-3.38	21.63	3.48
Normalized Net Income, 3 Yr. CAGR %	-11.43	0.53	-1.37	15.97	5.34
Diluted EPS Before Extra, 3 Yr. CAGR %	-13.98	0.83	-0.87	24.25	5.25
Accounts Receivable, 3 Yr. CAGR %	5.32	3.87	1.86	3.32	2.51
Inventory, 3 Yr. CAGR %	8.6	6.45	10.28	16.95	17.99
Net Property, Plant and Equip., 3 Yr. CAGR %	15.89	18.27	3.1	6.35	4.46
Total Assets, 3 Yr. CAGR %	5.88	5.44	5.32	6.37	5.73
Tangible Book Value, 3 Yr. CAGR %	3.45	4.61	0.81	9.68	7.63
Common Equity, 3 Yr. CAGR %	4.13	4.03	3.89	9.18	7.84
Cash From Operations, 3 Yr. CAGR %	24.43	23.37	-4.32	4.09	5.62
Capital Expenditures, 3 Yr. CAGR %	-10.49	-4.71	2.84	16.44	13.96
Levered Free Cash Flow, 3 Yr. CAGR %	16.47	-11.09	-21.03	25.1	6.49
Unlevered Free Cash Flow, 3 Yr. CAGR %	21.47	-7.43	-15.18	58.09	16.34
Dividend Per Share, 3 Yr. CAGR %	5.73	4.04	4.04	8.13	11.92
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.65	-1.21	-1.41	3.01	4.74
Gross Profit, 5 Yr. CAGR %	0.46	1.98	2.94	6.01	6.93
EBITDA, 5 Yr. CAGR %	1.34	2.33	2.75	5.04	6.5
EBITA, 5 Yr. CAGR %	-1.31	0.53	-0.15	5.49	7.03
EBIT, 5 Yr. CAGR %	-1.57	0.28	1.29	5.57	7.18
Earnings From Cont. Operations, 5 Yr. CAGR %	-6.2	2.49	-2.75	0.7	2.77
Net Income, 5 Yr. CAGR %	-5.86	2.7	-2.7	1.35	3.04
Normalized Net Income, 5 Yr. CAGR %	-4.46	0.27	-2.64	2.63	4.42
Diluted EPS Before Extra, 5 Yr. CAGR %	-4.78	4.42	-1.1	3.36	5.31
Accounts Receivable, 5 Yr. CAGR %	4.4	4.26	4.7	3.33	2.08
Inventory, 5 Yr. CAGR %	0.31	3.44	8.77	14.47	12.71
Net Property, Plant and Equip., 5 Yr. CAGR %	13.77	12.29	12.18	13.27	3.16
Total Assets, 5 Yr. CAGR %	4.29	4.91	5.97	6.04	5.24
Tangible Book Value, 5 Yr. CAGR %	5.35	5.57	2.99	6.08	6.54
Common Equity, 5 Yr. CAGR %	5.56	5.4	4.59	6.35	6.44
Cash From Operations, 5 Yr. CAGR %	16.5	13.58	9.93	16.17	4.52
Capital Expenditures, 5 Yr. CAGR %	-6.98	-1.51	0.54	2.52	6.46
Levered Free Cash Flow, 5 Yr. CAGR %	5.11	0.35	-4.64	-20.05	-10.67
Unlevered Free Cash Flow, 5 Yr. CAGR %	7.43	3.11	-0.18	-13.67	-6.38
Dividend Per Share, 5 Yr. CAGR %	11.26	10.38	5.34	5.34	9.57